DONADELLI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 7.565
EU - Europa 6.401
AS - Asia 4.453
SA - Sud America 644
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 118
OC - Oceania 16
Totale 19.388
Nazione #
US - Stati Uniti d'America 7.342
RU - Federazione Russa 2.457
SG - Singapore 1.624
CN - Cina 1.291
GB - Regno Unito 1.276
IT - Italia 899
BR - Brasile 509
VN - Vietnam 486
HK - Hong Kong 373
DE - Germania 340
FR - Francia 317
SE - Svezia 284
IE - Irlanda 243
FI - Finlandia 228
KR - Corea 142
BD - Bangladesh 118
CA - Canada 112
IN - India 80
UA - Ucraina 74
ID - Indonesia 71
TR - Turchia 60
MX - Messico 58
NL - Olanda 58
JP - Giappone 50
AR - Argentina 48
ES - Italia 46
PL - Polonia 41
BE - Belgio 39
EC - Ecuador 25
AT - Austria 24
ZA - Sudafrica 22
NG - Nigeria 21
SA - Arabia Saudita 20
IQ - Iraq 19
CO - Colombia 18
IR - Iran 15
BJ - Benin 14
PK - Pakistan 14
MY - Malesia 13
PH - Filippine 13
UZ - Uzbekistan 12
JM - Giamaica 11
VE - Venezuela 11
AU - Australia 10
CR - Costa Rica 10
LT - Lituania 10
MA - Marocco 10
PE - Perù 10
CL - Cile 9
TG - Togo 9
HN - Honduras 8
RO - Romania 7
AL - Albania 6
CH - Svizzera 6
DZ - Algeria 6
IL - Israele 6
NP - Nepal 6
TN - Tunisia 6
BO - Bolivia 5
JO - Giordania 5
KE - Kenya 5
PT - Portogallo 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
EG - Egitto 4
GR - Grecia 4
HU - Ungheria 4
KZ - Kazakistan 4
NO - Norvegia 4
TH - Thailandia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GA - Gabon 3
HR - Croazia 3
KW - Kuwait 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AG - Antigua e Barbuda 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
ML - Mali 2
MT - Malta 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
Totale 19.168
Città #
Southend 1.082
Ashburn 941
Moscow 879
Singapore 833
San Jose 751
Dallas 709
Chandler 676
Verona 377
Hong Kong 367
Jacksonville 364
Woodbridge 330
Ann Arbor 302
Beijing 250
Council Bluffs 240
Dublin 240
New York 232
The Dalles 183
Houston 159
Ho Chi Minh City 145
Los Angeles 128
Hanoi 99
Munich 99
Lawrence 93
Princeton 93
Wilmington 90
Nanjing 75
Jinan 70
Redmond 70
Helsinki 62
Shenyang 62
Santa Clara 61
Phoenix 60
São Paulo 58
Tianjin 57
Milan 54
Buffalo 53
Columbus 50
Jakarta 49
Hebei 48
Dong Ket 45
Redondo Beach 44
Tokyo 42
Orem 40
London 39
Brussels 36
Changsha 36
Redwood City 35
Seoul 33
Sindelfingen 33
Turku 33
Venice 33
Frankfurt am Main 32
Lappeenranta 32
Zhengzhou 32
Haikou 30
Montreal 30
Toronto 29
Nanchang 28
Warsaw 28
Brooklyn 27
Atlanta 26
Chicago 25
Düsseldorf 24
Seattle 24
Guangzhou 23
Ningbo 23
Boardman 22
Mexico City 22
Boston 21
Hangzhou 21
Jiaxing 21
Norwalk 21
Rio de Janeiro 21
Stockholm 21
Haiphong 20
Madrid 19
Chennai 18
Manchester 18
Rome 18
Amsterdam 17
Da Nang 17
Denver 17
Kent 17
Abuja 16
San Francisco 16
Taizhou 16
Nuremberg 15
Poplar 15
Augusta 14
Cotonou 14
Johannesburg 14
Taiyuan 13
Caserta 12
Las Vegas 12
McKinney 12
Vienna 12
Dhaka 11
Querétaro 11
Washington 11
Fuzhou 10
Totale 11.908
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 360
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 322
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 321
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 267
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 264
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 264
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 257
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 252
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 247
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 247
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 241
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 232
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 227
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 224
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 220
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 220
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 219
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 219
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 218
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 217
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 216
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 215
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 214
Proteomics in pancreatic cancer research. 211
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 208
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 208
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 206
Cell communication and signaling: how to turn bad language into positive one 205
Regulation of miR-23b expression and its dual role on ROS production and tumour development 202
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 202
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 200
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 198
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 196
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 189
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 188
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 187
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 186
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 185
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 182
UCP2, a mitochondrial protein regulated at multiple levels 181
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 181
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 181
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 181
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 180
Oncometabolites in cancer aggressiveness and tumour repopulation 178
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 173
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 173
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 171
Gut microbiota modulates seizure susceptibility 170
Mutant p53 and mTOR/PKM2 regulation in cancer cells 169
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 169
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 169
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 167
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 167
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 166
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 166
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells 165
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 165
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 163
Autocrine mechanisms of cancer chemoresistance 162
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 160
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 159
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 157
The metabolic landscape of cancer stem cells 157
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 154
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 152
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 149
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 149
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 148
Sex differences in neuromuscular and biological determinants of isometric maximal force 147
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 146
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 145
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 142
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 139
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 139
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 136
Regulation of succinate dehydrogenase and role of succinate in cancer 136
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 135
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 134
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 134
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 133
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity 132
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 132
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 130
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 128
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 127
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 125
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 124
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 123
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 122
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 120
null 119
The cancer secretome and secreted biomarkers 118
Proteomic Signature of PDAC Cells with Mutant p53 117
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 116
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 115
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 111
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 109
From single gene analysis to single cell profiling: a new era for precision medicine 108
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 107
Totale 17.767
Categoria #
all - tutte 66.062
article - articoli 60.306
book - libri 0
conference - conferenze 5.756
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022481 0 0 0 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024940 37 56 74 92 116 217 29 78 15 48 132 46
2024/20252.431 112 153 90 398 129 74 113 142 411 159 206 444
2025/20268.563 559 532 672 1.267 2.296 519 675 468 672 501 165 237
2026/2027981 126 192 321 342 0 0 0 0 0 0 0 0
Totale 19.388